Mereo BioPharma to Participate in Fireside Chat at the SVB Securities Global Biopharma Conference
LONDON, Feb. 08, 2023 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ:MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will participate in a fireside chat at the SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023 at 01:00pm GMT / 08:00am ET.
Related news for (MREO)
- Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
- Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market
- Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market
- Mereo BioPharma to Participate in Fireside Chat at the 22nd Annual Needham Healthcare Conference